期刊文献+

美洛昔康干乳的制备及其稳定性考察 被引量:3

下载PDF
导出
摘要 目的:对水不溶性的可选择性抑制环氧化酶-2型非甾体类抗炎药美洛昔康喷雾干燥乳剂(O/W)处方、质量检测方法进行研究,并考察其稳定性。方法:根据美洛昔康的溶解性筛选油及非水溶剂,选用乳化性能好的的固体载体,使用喷雾干燥法制备美洛昔康干乳,采用高效液相法测定美洛昔康含量,影响因素试验、长期试验考察其稳定性。结果:以Labrafac CC(HLB为1)作油相,麦芽糖糊精作固体载体,制得的干乳溶于纯化水后的平均粒径是喷雾干燥前匀质化乳剂平均粒径的1.4倍。恒温试验120d,UV照射对比试验24h(93.7%~35.5%),含量及粒径大小未见明显改变。结论:制得的非甾体抗炎药美洛昔康喷干乳质量可控,稳定性良好,与传统口服乳剂相比具有更多优势。
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2008年第20期1793-1795,共3页 Chinese Journal of Hospital Pharmacy
  • 相关文献

参考文献8

  • 1Dollo G, Le Corre P , Guerin A , etal. Spray-dried redispersible oil-in-water emulsion to improve oral bioavailability of poorly soluble drugs[J]. Eur J Pharm Sci, 2003, 19(4) : 273- 280.
  • 2Hansen T , Holmc P , Rohded M, et al. In vivo evaluation of tablets and capsules containing spray-dried o/ w-emulsions for oral delivery of poorly soluble drugs[J]. Int J Pharm , 2005 , 293 (1-2):2113 - 211.
  • 3吴伟明,诸乐恺,陈丽佳.美洛昔康栓剂的制备及质量控制[J].海峡药学,2006,18(4):32-34. 被引量:2
  • 4郑增娟,张建军,周建平,张奕华.非甾体抗炎药ZLR-8喷雾干燥乳剂的处方研究[J].中国药科大学学报,2006,37(1):33-36. 被引量:6
  • 5Hansen T, Holm P, Schultz K. Process characteristics and compaction of spray-dried emulsions containing a drug dissolved in lipid[J]. Int J Pharm ,2004,287(1-2):55-661.
  • 6Christensen KL , Pedersen GP , Kristensen HG. Physical stability of redispersible dry emulsions containing amorphous sucrose[J]. Eur J Pharm Biopharm,2002,53(2) : 147-153.
  • 7Lobenberg, R. , Amidon, G. L. , Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards[J]. Eur J Pharm Biopharn,2000 ,50(1 ) :3-12.
  • 8薛文静,朱家壁,杜凤梅.含药干乳的研究概况[J].药学进展,2006,30(12):547-551. 被引量:5

二级参考文献45

  • 1冯晓春,季晖,张奕华,殷志勇.ZLR-8对大鼠胃溃疡愈合的影响及体外一氧化氮释放作用[J].中国药科大学学报,2004,35(4):357-360. 被引量:20
  • 2王鸿,杨纲,梁文权.盐酸布比卡因冻干乳剂的制备[J].海峡药学,2004,16(4):21-22. 被引量:7
  • 3王从容,赵娥.美洛昔康凝胶的制备[J].中国医院药学杂志,2005,25(4):369-370. 被引量:9
  • 4Dollo G,Le Corre P, Guerin A, et al. Spray-dried redispersible oil-in-water emulsion to improve oral bioavailability of poorly soluble drugs[J]. Eur J Pharm Sci ,2003,19(4) :273 - 280.
  • 5Hansen T, Holmc P, Rohded M, et al, In vivo evaluation of tablets and capsules containing spray-dried o/w-emulsions for oral delivery of poorly soluble drugs [J]. Int J Pharm, 2005,293(1-2):203-211.
  • 6Toorisaka E, Hashida M, Kamiya N, et al. An enteric-coated dry emulsion formulation for oral insulin delivery [J]. J Controlled Release ,2005,107(1):91 - 96.
  • 7Hansen T, Holm P, Schultz K. Process characteristics and compaction of spray-dried emulsions containing a drug dissolved in lipid[J].Int J Pharm,2004,287(1 - 2) :55 - 66.
  • 8Corveleyn S, Remon JP, Bioavailability of hydrochlorothiazide:conventional versus freeze-dried tablets[J]. Int J Pharm, 1998,173(1 -2):149- 155.
  • 9Corveleyn S, Remon JP. Formulation of a lyophilized dry emulsion tablet for tile delivery of poorly soluble drugs[J]. Int J Pbarm,1998,166(1 ) :65 - 74.
  • 10Christensen KL, Pedersen GP, Kristensen HG. Preparation of redispersible dry emulsions by spray drying[J]. Int J Pharm ,2001,212(2) : 187 - 194.

共引文献10

同被引文献2004

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部